Moray Medical, a startup focused on augmented reality-based cardiovascular care, recently secured $3.3 million for its interventional robotics platform to enhance heart procedures.
Mountain View, California-based Moray’s new system, known as Coral, is meant to simplify a number of minimally invasive heart interventions, focusing specifically on the transcatheter mitral valve repair market.
“While transcatheter edge-to-edge repair (TEER), or clip therapy, is rapidly becoming the new clinical standard of care, the complexity and learning curve associated with current devices means that the vast majority of needy patients are being left untreated,” Co-founder and CEO Mark Barrish said in a statement. “Our platform is aimed at empowering interventionalists at all skill levels to carry out these procedures in a cost-efficient manner to ensure that millions of additional sick patients get the lifesaving treatment they deserve.”
415Capital led this round of seed funding, along with a number of other “prominent” medtech investors, the firm announced Wednesday.
Moray also said that 415Capital’s Senior Venture Partner Azin Parhizgar, PhD, will join Moray’s board of directors.